FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W34229074> ?p ?o ?g. }

• W34229074 endingPage "7" @default.
• W34229074 startingPage "6" @default.
• W34229074 abstract "Gifts, grants, and from the drug industry have become so entrenched in American medical institutions that most of us no longer even notice their presence. But this may soon change. The Office of the Inspector General (OIG) in the Department of Health and Human Services has warned the drug industry that many of its marketing practices may violate federal fraud and laws. A new fifty-six-page compliance guide issued on 28 April says that federal anti-kickback laws prohibit drug manufacturers from making payments to doctors, drug purchasers, and others with the intention of encouraging them to prescribe the manufacturer's drugs. Under federal law, it is a felony for a drug company to give something of value to a person to induce them to generate business reimbursable under Medicare or Medicaid. Practices with a high potential for fraud and abuse include gifts, entertainment, and personal services compensation arrangements. When the OIG published a draft of the compliance guide in October, it was swiftly denounced by industry representatives, physicians, and professional medical societies. According to the New York Times, industry representatives ac knowledged that they routinely make payments to insurance plans to increase the use of their products and to reward doctors and pharmacists for switching patients to their drugs. But they claimed these payments were well-established commercial practices. The OIG was apparently unconvinced. Its compliance guide specifically warns against giving doctors fees to listen to business presentations, compensating them for signing ghost-written articles or delivering ghostwritten speeches, and providing them with travel, meals, or entertainment in association with informational presentations. Entrepreneurial bioethicists may also want to read the compliance guide carefully. It states that its warnings apply not merely to payments to physicians and insurers, but to anyone in a position to generate federal health care business, including (but not limited to) allied health professionals, hospital formulary committee members, and pharmacists. Many bioethicists and bioethics centers actively seek out funding from the drug industry, either for personal consulting arrangements or for institutional support. Paid consultation to private industry was endorsed in 2002 by a task force appointed by the American Society for Bioethics and Humanities and the American Society for Law, Medicine and Ethics [HCR 32, no. …" @default.
• W34229074 created "2016-06-24" @default.
• W34229074 creator A5003676849 @default.
• W34229074 date "2003-09-16" @default.
• W34229074 modified "2023-09-23" @default.
• W34229074 title "Taking money from the drug industry: the rules tighten." @default.
• W34229074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12971053" @default.
• W34229074 hasPublicationYear "2003" @default.
• W34229074 type Work @default.
• W34229074 sameAs 34229074 @default.
• W34229074 citedByCount "0" @default.
• W34229074 crossrefType "posted-content" @default.
• W34229074 hasAuthorship W34229074A5003676849 @default.
• W34229074 hasConcept C10138342 @default.
• W34229074 hasConcept C121955636 @default.
• W34229074 hasConcept C144133560 @default.
• W34229074 hasConcept C145097563 @default.
• W34229074 hasConcept C160735492 @default.
• W34229074 hasConcept C162324750 @default.
• W34229074 hasConcept C17744445 @default.
• W34229074 hasConcept C181907467 @default.
• W34229074 hasConcept C187736073 @default.
• W34229074 hasConcept C199521495 @default.
• W34229074 hasConcept C199539241 @default.
• W34229074 hasConcept C2776534028 @default.
• W34229074 hasConcept C2779913896 @default.
• W34229074 hasConcept C2909375031 @default.
• W34229074 hasConcept C3018364242 @default.
• W34229074 hasConceptScore W34229074C10138342 @default.
• W34229074 hasConceptScore W34229074C121955636 @default.
• W34229074 hasConceptScore W34229074C144133560 @default.
• W34229074 hasConceptScore W34229074C145097563 @default.
• W34229074 hasConceptScore W34229074C160735492 @default.
• W34229074 hasConceptScore W34229074C162324750 @default.
• W34229074 hasConceptScore W34229074C17744445 @default.
• W34229074 hasConceptScore W34229074C181907467 @default.
• W34229074 hasConceptScore W34229074C187736073 @default.
• W34229074 hasConceptScore W34229074C199521495 @default.
• W34229074 hasConceptScore W34229074C199539241 @default.
• W34229074 hasConceptScore W34229074C2776534028 @default.
• W34229074 hasConceptScore W34229074C2779913896 @default.
• W34229074 hasConceptScore W34229074C2909375031 @default.
• W34229074 hasConceptScore W34229074C3018364242 @default.
• W34229074 hasIssue "4" @default.
• W34229074 hasLocation W342290741 @default.
• W34229074 hasOpenAccess W34229074 @default.
• W34229074 hasPrimaryLocation W342290741 @default.
• W34229074 hasRelatedWork W2097282683 @default.
• W34229074 hasRelatedWork W2408929772 @default.
• W34229074 hasRelatedWork W2900963902 @default.
• W34229074 hasRelatedWork W2915785887 @default.
• W34229074 hasRelatedWork W34229074 @default.
• W34229074 hasRelatedWork W4236706717 @default.
• W34229074 hasRelatedWork W4254848128 @default.
• W34229074 hasRelatedWork W4255435140 @default.
• W34229074 hasRelatedWork W1639309846 @default.
• W34229074 hasRelatedWork W2243503006 @default.
• W34229074 hasVolume "33" @default.
• W34229074 isParatext "false" @default.
• W34229074 isRetracted "false" @default.
• W34229074 magId "34229074" @default.
• W34229074 workType "article" @default.